fbpx

Study: Female Androgenetic Alopecia

Platelet-Rich Plasma in Female Androgenetic Alopecia: A Comprehensive Systematic Review and Meta-Analysis In this work, Zhou et al.3 summarize different treatment regimes in female androgenetic alopecia (AGA), and quantitively analyze the efficacy of PRP in this disease. They evaluated 636 studies and 12 trials from six databases (MEDLINE, EMBASE, Web of Science, Cochrane Central Register of Controlled… Continue reading Study: Female Androgenetic Alopecia

Read more...

New Medical Device Regulation

Platelet-Rich Plasma in The new Medical Devices Regulation (2017/745/EU), applicable since May 2021 in EU, will replace the existing Medical Devices Directives (93/42/EEC). This regulation provides a framework for the manufacture, modification, and use of devices when equivalent devices are not commercially available (Article 5 of the Medical Device Regulation). In these situations, health care… Continue reading New Medical Device Regulation

Read more...

New Patents

For Regenkit®/ RegenPRP® products (PRP alone technology) For its Regenkit®/RegenPRP® products (PRP alone technology), the United States Patent and Trademark Office (USPTO) has recently issued U.S. Patents No. 11,241,458 directed to (i) several types of sterilized, vacuum-sealed, separator tubes (therapeutic and aesthetic use) for preparing PRP comprising an anticoagulant and a thixotropic gel and (ii) methods for preparing… Continue reading New Patents

Read more...

Study: Orthopedic surgery

Autologous regenerative stimulants for bone allograft implantation In their report, Vorobyov et al. present a clinical case where a combination of allogeneic osteoplastic materials with autologous platelet-rich plasma is used to reconstruct a cavity defect in the tibia. Firstly, the authors describe the basic principles of orthobiology and the different surgical techniques for bone reconstruction using bone… Continue reading Study: Orthopedic surgery

Read more...

Webinar #10 of Biobridge Winter Season 2022

Monday, March 28th, we were fortunate to have Sarah Berndt, PhD, Geneva University and Dr Jasmine Abdulcadir, HUG-Geneva, discussing the value of PRP and PRP+HA as autologous treatments for vulvo-vaginal atrophy. Sarah Berndt described the consequence of the menopause on vaginal tissues (dryness, loss of elasticity, decrease in vaginal epithelium). She presented in vitro evidence… Continue reading Webinar #10 of Biobridge Winter Season 2022

Read more...

The AMWC 2022

We can’t wait to see you again at the AMWC, New Location New Booth, Hall Diaghilev E18 Regen Lab will feature its brandnew Regen4D Cosmeceutical Technology, empowered in RegenSkin topical line. Get trained and discuss Regen Lab Experts Techniques and Protocols Thursday March 31,in the “Injection Room” GERALDY with Dr Ghislaine Beilin (Paris, FR) | 10:00 AM… Continue reading The AMWC 2022

Read more...

AAOS 2022

Regen Lab is pleased to announce their attendance at AAOS 2022. We are now proudly manufacturing in Brooklyn, New York’s Biotechnology & Life Sciences District. RegenLab® is a global leader in innovative biological non-operative and surgical solutions, dedicated to patient safety, quality manufacturing systems, regulatory adherence, and the advancement of regenerative therapeutics through evidence-based medicine.

Read more...

Webinar #8 of Biobridge Winter Season 2022

Monday, March 14th, we were fortunate to have Dr. Sebastien Beley, Urology Surgeon, along with Ms Antonia Mariconda, considering the social trends, causes and treatment options specifically for Peyronie’s Disease and Erectile Dysfunction. This discussion was led by Laurence Desbordes, journalist specialized in lifestyle, fashion and health. Ms Antonia Mariconda gave the key figures for… Continue reading Webinar #8 of Biobridge Winter Season 2022

Read more...